Clinical Trials Logo

Clinical Trial Summary

An 8 week clinical study to evaluate the ability of an experimental dentifrice containing calcium sodium phosphosilicate and sodium fluoride to provide relief from dentine hypersensitivity compared to a marketed dentifrice containing calcium sodium phosphosilicate and sodium monofluorophosphate.


Clinical Trial Description

A single centre, multi-site, randomised, examiner blind, two treatment, parallel group, non-inferiority design clinical study conducted in healthy subjects with self-reported and clinically diagnosed dentine hypersensitivity (DH). This study will compare the effectiveness of a test dentifrice containing 5% w/w calcium sodium phosphosilicate and fluoride as sodium fluoride to a commercially available dentifrice containing 5% w/w calcium sodium phosphosilicate and fluoride as sodium monofluorophosphate, in providing relief from DH after 4 and 8 weeks twice daily treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02371616
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase N/A
Start date September 29, 2014
Completion date December 18, 2014

See also
  Status Clinical Trial Phase
Completed NCT02789618 - A Pilot Study to Substantiate the Use of the Jay Sensitivity Sensor Probe N/A